I would agree that drugs which have passed Phase 2 trials should made available to "mercy" patients during Phase 3 trials for patients that were not able to get into the trial...at cost to the pharmaceutical company that hopes to sell the drug/

This would eliminate the profit motive that other commentators have noted would be a huge issue.